Foot Locker, Inc. (FL)
Stock analysis · NYSE · Consumer Cyclical · Apparel - Retail
Foot Locker, Inc. (FL) is a publicly traded company in the Consumer Cyclical sector. Latest price: $24.01. Market cap $2.29B. Trailing PE -5.70. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Earnings
Proprietary Signals
About Foot Locker, Inc.
Foot Locker, Inc. operates as a leading global retailer specializing in athletic footwear, apparel, and associated accessories, equipment, and licensed team merchandise. The company distributes these products through a portfolio of well-known brand names, including Foot Locker, Lady Foot Locker, Kids Foot Locker, Champs Sports, Eastbay, atmos, WSS, Footaction, and Sidestep. As of January 29, 2022, its vast retail network comprised 2,858 company-owned stores spanning 28 countries, such as the United States, Canada, various European nations, Australia, New Zealand, and parts of Asia. Additionally, Foot Locker maintained 142 franchised stores located predominantly in the Middle East and Asia. Beyond its physical stores, the company also makes its offerings available to customers through various e-commerce platforms and dedicated mobile applications. Foot Locker, Inc. was established in 1879 and is headquartered in New York, New York.
Valuation
| P/E (TTM) | -5.70× |
|---|---|
| P/S (TTM) | 0.63× |
| P/B | 0.89× |
| PEG | 0.00× |
| P/FCF (TTM) | -21.86× |
| EV / EBITDA | -24.69× |
| EV / Sales | 1.31× |
| Earnings Yield | -17.53% |
| Free Cash Flow Yield | -4.58% |
Fundamentals
| Enterprise Value | $4.76B |
|---|---|
| Revenue (TTM) | $3.65B |
| Net Income (TTM) | -$402.16M |
| Free Cash Flow (TTM) | -$98.32M |
| Net Debt | $2.47B |
| Working Capital | $883.00M |
| Gross Margin | 26.60% |
| Operating Margin | -7.72% |
| Net Margin | -10.98% |
| Return on Equity | -15.46% |
| Return on Invested Capital | -5.12% |
Peers
Recent News
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Dicks Sporting Goods Inc. to Contact Law Firm
- Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Su…
- AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus…
- DICK'S Sporting Goods: Foot Locker's Weakness Did Not Make It Cheap Enough
- "It Has Really Hurt My Long-Term Performance": Jim Cramer Admits His Own Charity Is Losing Money By Using Wrong Dividend Strategy
Related
Browse more tickers: sitemap